Modifiers are identified through a combination of epidemiological studies, genomic research, and clinical trials. Large-scale studies that track health outcomes in diverse populations can reveal associations between potential modifiers and cancer risk or outcomes. Advances in genomic technologies have enabled researchers to identify genetic variants that act as modifiers. Clinical trials often include the analysis of potential modifiers to understand their impact on treatment efficacy and safety.
